Cointime

Deargen

company

About

Deargen provides AI-based genome analysis service.

  • 11 - 50

Highlights

Total Funding Amount
$17M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$17M
Industries
Artificial Intelligence,Biotechnology,Machine Learning
Founded date
Dec 6, 2016
Number Of Employee
11 - 50
Operating Status
Active

Deargen provides AI-based genome analysis service.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$17M
Deargen has raised a total of $17M in funding over 2 rounds. Their latest funding was raised on Feb 24, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 24, 2022 Series B $17M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Deargen is funded by 1 investors. Nvestor (Korea) are the most recent investors.
Investor Name Lead Investor Funding Round
Nvestor (Korea) — Series B
Cointime
Content
Company